These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14668178)

  • 1. Cardioversion of persistent atrial fibrillation--not yet an outdated treatment.
    Gjesdal K
    Scand Cardiovasc J; 2003 Dec; 37(6):307-8. PubMed ID: 14668178
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
    Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Med Clin North Am; 2008 Jan; 92(1):101-20, xi. PubMed ID: 18061000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B; Straumann E; Bertel O
    Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrical cardioversion of atrial fibrillation: different methods for a safe and effective technique.
    Santini L; Forleo GB; Topa A; Romeo F; Santini M
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):601-10. PubMed ID: 16076271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioversion of atrial fibrillation for maintenance of sinus rhythm: a road to nowhere.
    Wyse DG; Anter E; Callans DJ
    Circulation; 2009 Oct; 120(14):1444-52. PubMed ID: 19805661
    [No Abstract]   [Full Text] [Related]  

  • 7. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Lombardi F; Tundo F; Belletti S; Mantero A; Melzi D'eril GV
    J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):581-8. PubMed ID: 18475126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Cardiol Clin; 2009 Feb; 27(1):95-107, ix. PubMed ID: 19111767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of plasma B-type natriuretic peptide in predicting recurrence of atrial fibrillation one year after external cardioversion.
    Lellouche N; Berthier R; Mekontso-Dessap A; Braconnier F; Monin JL; Duval AM; Dubois-Randé JL; Guéret P; Garot J
    Am J Cardiol; 2005 Jun; 95(11):1380-2. PubMed ID: 15904651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation.
    Siu CW; Jim MH; Zhang X; Chan YH; Pong V; Kwok J; Kung AW; Lau CP; Tse HF
    Am J Cardiol; 2009 Feb; 103(4):540-3. PubMed ID: 19195517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioversion and the endothelium in atrial fibrillation.
    Lip GY; Freestone B
    Thromb Res; 2006; 117(3):231-3. PubMed ID: 15927240
    [No Abstract]   [Full Text] [Related]  

  • 12. Atrial stunning as predictor of early relapse into atrial fibrillation after cardioversion.
    Climent V; Marín F; Monmeneu JV; García de Burgos F; Sogorb F
    Int J Cardiol; 2006 Jun; 110(3):427-8. PubMed ID: 16378649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal changes in atrial refractoriness following DC cardioversion of persistent atrial fibrillation in man.
    Spurrell P; Kamalvand K; Higson M; Sulke N
    Europace; 2004 May; 6(3):229-35. PubMed ID: 15121076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion.
    Boriani G; Diemberger I; Biffi M; Camanini C; Valzania C; Corazza I; Martignani C; Zannoli R; Branzi A
    Int J Cardiol; 2005 Jun; 101(3):355-61. PubMed ID: 15907401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrical cardioversion for persistent or chronic atrial fibrillation: outcome and clinical factors predicting short and long term success rate.
    Blich M; Edoute Y
    Int J Cardiol; 2006 Mar; 107(3):389-94. PubMed ID: 16503261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-limited bursts of atrial fibrillation following successful cardioversion.
    Nergårdh AK; Rosenqvist M; Frick M
    Int J Cardiol; 2007 Jun; 119(1):95-100. PubMed ID: 17064786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internal cardioversion as a first-line method of cardioversion?
    Crijns HJ
    Europace; 2001 Jan; 3(1):2-3. PubMed ID: 11271946
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
    Wozakowska-Kapłon B; Opolski G
    Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oesophageal electrical cardioversion of atrial fibrillation.
    Santini L; Forleo GB; Santini M; Romeo F
    Minerva Cardioangiol; 2004 Apr; 52(2):73-80. PubMed ID: 15194990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome after cardioversion of atrial fibrillation: prediction of recurrence with P wave signal averaged ECG and chemoreflexsensitivity.
    Budeus M; Wieneke H; Sack S; Erbel R; Perings C
    Int J Cardiol; 2006 Oct; 112(3):308-15. PubMed ID: 16309759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.